(Press-News.org) Heart attack patients die at a higher rate when their nearest emergency room is so overtaxed that the ambulance transporting them is dispatched to another hospital, according to a new study led by scientists at the University of California, San Francisco.
The findings will be published online June 12, 2011 by JAMA, the Journal of the American Medical Association. The research also will be presented on June 13, 2011 at the AcademyHealth's annual research meeting in Seattle, WA.
"This is one of the first studies to tie patient-level outcomes to daily ambulance diversion logs across multiple cities and counties," says senior author Renee Y. Hsia, MD, assistant professor of emergency medicine at UCSF. She also works as an emergency physician attending at San Francisco General Hospital.
"Everyone knows that ER crowding is a problem. What people need to know is whether crowding affects them and their health. Those of us who work in the ER know that when it's crowded, it affects our ability to provide optimal care. In the study, we finally show that when ambulances are diverted, the outcomes of patients with acute myocardial infarction are worse. In fact, for every 100 patients who are unfortunate enough to have a heart attack when ambulances are being diverted for long periods of time, our study shows that there are three potentially avoidable deaths."
Ambulance diversion is triggered when a hospital's ER is too busy to accept new patients. The ER is temporarily closed, and the ambulance takes the patient to the next available ER, sometimes miles away. For patients undergoing a heart attack, the lost time can be critical.
Ambulance diversion is a particularly common practice in urban settings. The National Center for Health Statistics has estimated that hospitals divert more than half a million ambulances annually in the United States, especially in winter, averaging about one ambulance every minute.
The study examined the outcomes of 13,860 Medicare patients admitted between 2000 and 2005, as well as daily ambulance logs from four densely populated counties in California – Los Angeles, San Francisco, San Mateo and Santa Clara. The counties represent 63 percent of the state's population. The data encompassed 508 different zip codes and 149 emergency departments.
When the closest ER was on diversion status for at least 12 hours, long-term mortality rates of patients rose during a 30-day, 90-day, 9-month and 1-year period. For example, the 30-day mortality rate of heart attack patients unaffected by diversion on their day of admission was 15 percent compared to an 18 percent mortality rate for patients admitted to the hospital on days with more than 12 hours of diversion. One-year mortality for patients not affected by diversion was 29 percent compared to 32 percent for diverted patients, even when controlling for age, co-morbidities, catheterization capabilities, hospital size, and other factors.
The authors say the study points to the need for hospitals to reapportion resources to reduce ER crowding and prolonged ambulance diversion.
"While demand on emergency care is increasing…supply of emergency care is decreasing," the authors note. "If these issues are not addressed on a larger scale, ED conditions will deteriorate, leaving significant implications for all."
INFORMATION:
The study was supported by funding from the Robert Wood Johnson Foundation, the National Institutes of Health/National Center for Research Resources, and the Clinical & Translational Science Institute at UCSF. The sponsors had no role in the design and conduct of the study, in the gathering and analysis of data or the writing of the report.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
Follow UCSF on Twitter @ucsf/@ucsfscience
Heart attack death rates linked to ambulance diversion
2011-06-14
ELSE PRESS RELEASES FROM THIS DATE:
Aurora A may contribute to kidney disease
2011-06-14
The Aurora A kinase may contribute to polycystic kidney disease (PKD) by inactivating a key calcium channel in kidney cells, according to a study in the June 13 issue of The Journal of Cell Biology (www.jcb.org).
Aurora A is an oncogene best known as a regulator of mitotic progression. But the kinase has important functions during interphase as well, when it can promote cilia disassembly and can be activated by elevated calcium levels. Because both calcium signaling and cilia are defective in PKD, researchers from the Fox Chase Cancer Center in Philadelphia wondered whether ...
High rates of injection drug use in urban Aboriginal youth signal need for prevention programs
2011-06-14
A new study indicates high rates of injection drug use in urban Canadian Aboriginal youth, particularly in women, and points to the need for culturally specific prevention programs, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101257.pdf
Aboriginal leadership is alarmed at the levels of substance abuse in their young people, especially injection drug use, which is associated with HIV and hepatitis C virus infections. Injection drug use accounts for 70%% of all hepatitis C virus and almost ...
Health data can help address alcohol-related harm in youth
2011-06-14
Administrative information can be useful for surveillance and understanding of alcohol-related harm in young people, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj110367.pdf
Binge drinking and overconsumption of alcohol by young people is a growing issue in many countries. For example, in a 2009 study, almost 60% of young Canadians aged 15-24 reported having consumed alcohol in the previous month, with 22% reporting heaving drinking and 20% experiencing harm related to alcohol consumption. In Australia, ...
Safe prescribing information for children in Canada often hard to find
2011-06-14
Accurate, safe prescribing information for children is often unavailable to doctors in Canada because pharmaceutical companies will not disclose information to Health Canada, states an editorial in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj110563.pdf
Health professionals in Canada as well as other countries such as Japan and Australia, unlike their colleagues in the United States and Europe, do not have access to the same body of evidence regarding pediatric dosing.
"As a consequence, Canadian children and youth ...
Glowing Cornell dots -- a potential cancer diagnostic tool set for human trials
2011-06-14
NEW YORK – The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
A paper describing this new medical technology, "Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma," will be published June 13, 2011 in the Journal of Clinical Investigation (July 2011). This is a collaboration between Memorial Sloan-Kettering Cancer Center (MSKCC), Cornell University, and Hybrid Silica ...
More genetic diseases linked to potentially fixable gene-splicing problems
2011-06-14
PROVIDENCE, R.I. [Brown University] — A new Brown University computer analysis that predicts the effect of genetic mutations on how the body splices mRNA indicates as many as a third of disease-related mutations may be linked to splicing problems — more than double the proportion previously thought.
"Something like 85 percent of the mutations in the Human Gene Mutation Database are presumed to affect how proteins are coded, but what this work shows is that 22 percent of those are affecting the splicing process," said William Fairbrother, assistant professor of biology ...
Decoding chronic lymphocytic leukemia
2011-06-14
A paper published online on June 13 in the Journal of Experimental Medicine (www.jem.org) identifies new gene mutations in patients with chronic lymphocytic leukemia (CLL)—a disease often associated with lack of response to chemotherapy and poor overall survival.
CLL is the most common leukemia in the Western world, but the disease varies greatly from patient to patient with regard to prognosis, survival, and disease course. In attempt to understand the genetic basis for this heterogeneity, a group led by Riccardo Dalla-Favera at Columbia University and Gianluca Gaidano ...
NIH researchers find new clues about aging
2011-06-14
National Institutes of Health researchers have identified a new pathway that sets the clock for programmed aging in normal cells. The study provides insights about the interaction between a toxic protein called progerin and telomeres, which cap the ends of chromosomes like aglets, the plastic tips that bind the ends of shoelaces.
The study by researchers from the National Human Genome Research Institute (NHGRI) appears in the June 13, 2011 early online edition of the Journal of Clinical Investigation.
Telomeres wear away during cell division. When they degrade sufficiently, ...
Sniffing out a new source of stem cells
2011-06-14
A team of researchers, led by Emmanuel Nivet, now at the Salk Institute for Biological Studies, La Jolla, has generated data in mice that suggest that adult stem cells from immune system tissue in the smell-sensing region of the human nose (human olfactory ecto–mesenchymal stem cells [OE-MSCs]) could provide a source of cells to treat brain disorders in which nerve cells are lost or irreparably damaged.
Stem cells are considered by many to be promising candidate sources of cells for the regeneration and repair of tissues damaged by various brain disorders (including traumatic ...
JCI online early table of contents: June 13, 2011
2011-06-14
EDITOR'S PICK: Sniffing out a new source of stem cells
A team of researchers, led by Emmanuel Nivet, now at the Salk Institute for Biological Studies, La Jolla, has generated data in mice that suggest that adult stem cells from immune system tissue in the smell-sensing region of the human nose (human olfactory ecto–mesenchymal stem cells [OE-MSCs]) could provide a source of cells to treat brain disorders in which nerve cells are lost or irreparably damaged.
Stem cells are considered by many to be promising candidate sources of cells for the regeneration and repair ...